These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3956522

  • 1. Effect of sotalol, aprindine and the combination aprindine-sotalol on monophasic action potential duration.
    Stroobandt R, Brachmann J, Kesteloot H, Kübler W, Senges J.
    Eur Heart J; 1986 Jan; 7(1):47-53. PubMed ID: 3956522
    [Abstract] [Full Text] [Related]

  • 2. Effects of aprindine on monophasic action potentials.
    Matsumoto K, Dohi Y, Asano Y, Kaneko K.
    J Electrocardiol; 1991 Apr; 24(2):113-20. PubMed ID: 2037813
    [Abstract] [Full Text] [Related]

  • 3. Effect of sotalol, aprindine and their combination on maximum upstroke velocity of action potential in guinea-pig papillary muscle.
    Stroobandt R, Kesteloot H.
    Eur J Pharmacol; 1986 Nov 19; 131(2-3):249-56. PubMed ID: 3816955
    [Abstract] [Full Text] [Related]

  • 4. [Effects of injectable aprindine in dogs, with special reference to the recording of atrial and ventricular monophasic action potentials and the bundle of His electrogram].
    Puech P, Cabasson J, Mellet JM, Guimond C.
    Therapie; 1974 Nov 19; 29(5):731-40. PubMed ID: 4462224
    [No Abstract] [Full Text] [Related]

  • 5. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
    Merot J, Charpentier F, Poirier JM, Coutris G, Weissenburger J.
    Cardiovasc Res; 1999 Nov 19; 44(2):303-14. PubMed ID: 10690307
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Electrophysiological effects of aprindine on A-V conduction in the dog.
    Ferrero Cabedo JA, Insa Pérez LD, López Merino V, Botella Solana S, Brugger Auban A, Esplugues Requena J.
    Arch Int Pharmacodyn Ther; 1978 Nov 19; 236(1):154-63. PubMed ID: 747461
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 19; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 9. Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents.
    Vanoli E, Priori SG, Nakagawa H, Hirao K, Napolitano C, Diehl L, Lazzara R, Schwartz PJ.
    J Am Coll Cardiol; 1995 Jun 19; 25(7):1609-14. PubMed ID: 7759713
    [Abstract] [Full Text] [Related]

  • 10. Effects of intravenous sotalol, aprindine and the combination of sotalol and aprindine on chronic high frequency ventricular arrhythmias in man.
    Stroobandt R, Holvoet G, Verbeke N, Kesteloot H.
    Eur Heart J; 1987 Apr 19; 8(4):372-7. PubMed ID: 2440683
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L, Cui G, Sakaguchi Y, Singh BN.
    J Pharmacol Exp Ther; 1998 May 19; 285(2):687-94. PubMed ID: 9580614
    [Abstract] [Full Text] [Related]

  • 12. Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle.
    Schmitt C, Brachmann J, Karch M, Waldecker B, Navarrete L, Montero M, Beyer T, Kübler W.
    Am J Cardiol; 1991 Nov 01; 68(11):1183-7. PubMed ID: 1951078
    [Abstract] [Full Text] [Related]

  • 13. Effects of aprindine HCL on cardiac tissues.
    Elharrar V, Foster PR, Zipes DP.
    J Pharmacol Exp Ther; 1975 Nov 01; 195(2):201-5. PubMed ID: 1185591
    [Abstract] [Full Text] [Related]

  • 14. Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia.
    Dennis PD, Vaughan Williams EM.
    Br J Pharmacol; 1985 May 01; 85(1):11-9. PubMed ID: 4027460
    [Abstract] [Full Text] [Related]

  • 15. Sotalol exhibits reverse use-dependent action on monophasic action potentials in normal but not in infarcted canine ventricular myocardium.
    Schmitt C, Beyer T, Karch M, Montero M, Hilbel T, Brachmann J, Kübler W.
    J Cardiovasc Pharmacol; 1992 Apr 01; 19(4):487-92. PubMed ID: 1380589
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C, Drolet B, Hamelin BA, Turgeon J.
    J Pharmacol Exp Ther; 1997 Oct 01; 283(1):148-56. PubMed ID: 9336319
    [Abstract] [Full Text] [Related]

  • 18. Prolongation of cardiac conduction times by intravenous aprindine in man.
    Greene HL, Reid PR, Schaeffer AH.
    Am J Cardiol; 1978 Dec 01; 42(6):1002-6. PubMed ID: 727127
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Electrophysiologic effects of sotalol on the immature mammalian heart.
    Houyel L, Fournier A, Ducharme G, Chartrand C, Davignon A.
    J Cardiovasc Pharmacol; 1992 Jan 01; 19(1):134-9. PubMed ID: 1375680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.